Braxia Scientific to Commence Landmark Clinical Trial to Conduct Canada's First Multiple-Dose Psilocybin Clinical Trial for Treatment Resistant Depression

/PRNewswire/ - Braxia Scientific Corp. ("Braxia Scientific", or the "Company"), (CSE: BRAX) (OTC: BRAXF) (FWB: 496), a medical research company with clinics...

Related Keywords

Montreal ,Quebec ,Canada ,Toronto ,Ontario ,Ottawa ,Canadian ,Roger Mcintyre ,Rogers Mcintyre ,Joshua Rosenblat ,Braxia Scientific Corp ,Excellence Inc ,Braxia Health Canadian Rapid Treatment Centers ,Braxia Institute ,Canadian Rapid Treatment Centre Of Excellence Inc ,Canadian Rapid Treatment Center ,Braxia Health ,Canadian Rapid Treatment Centers ,Braxia Scientific ,Canadian Rapid Treatment Centre ,Controlled Drugs ,Substances Act ,Restated Listing Statement ,